Health & Life Sciences

PARIS; Dec. 11, 2018 – Pierre Fabre has selected Accenture (NYSE: ACN) to build an intelligent information technology (IT) platform to support and improve the performance of a range of functions ? including finance, accounting, procurement, order management and manufacturing ? essential to the company’s global operations. The program is part of one of the most significant and strategic transformation initiatives ever undertaken at the French multinational health and beauty care company.

NEW YORK and LAS VEGAS; Nov. 26, 2018 – Accenture (NYSE: ACN) has created an open partner ecosystem designed to help independent software vendors (ISVs) and life sciences companies team more effectively to accelerate drug discovery efforts and, ultimately, improve patient outcomes.

NEW YORK; Sept. 21, 2018 – Accenture (NYSE: ACN) has enhanced the Accenture Intelligent Patient Platform with the addition of Ella and Ethan, two interactive virtual-assistant bots that use artificial intelligence (AI) to constantly learn and make intelligent recommendations for interactions between life sciences companies, patients, health care providers (HCPs) and caregivers. Designed to help improve a patient’s health and overall experience, the bots are part of Accenture’s Salesforce Fullforce Solutions powered by Salesforce Health Cloud and Einstein AI, as well as Amazon’s Alexa.  

NEW YORK; Sept. 17, 2018 – Accenture and Merck, known as MSD outside the United States and Canada, in collaboration with Amazon Web Services (AWS), will launch a cloud-based informatics research platform designed to help organizations in the life sciences industry improve productivity, efficiency and innovation in the early stages of drug development.

NEW YORK; Aug. 21, 2018 – Accenture (NYSE: ACN) is positioned for a third consecutive time as a Leader in the IDC MarketScape vendor assessment, covering strategic consulting across the life sciences research and development (R&D) industry.

NEW YORK; July 30, 2018 – For the third consecutive time, Accenture (NYSE: ACN) is positioned as a Leader in the IDC MarketScape vendor assessment covering IT outsourcing (ITO) across the life sciences research and development (R&D) industry. 

NEW YORK; July 12, 2018 – Accenture (NYSE: ACN) has been named a Leader in an IDC Health Insights IDC MarketScape vendor assessment covering business process outsourcing (BPO) across the life sciences research and development (R&D) industry. This is the third consecutive time Accenture Life Sciences has achieved this prestigious ranking.

NEW YORK; July 2, 2018 – Accenture (NYSE: ACN) has kicked off the application period for the third annual Accenture HealthTech Innovation Challenge, which seeks to improve the way people access and manage healthcare.

NEW YORK; June 20, 2018 – Accenture is the recipient of the 2018 Frost & Sullivan North American Market Leadership Award for real-world evidence (RWE) enterprise solutions.

NEW YORK; Jan. 10, 2018 – When launching new products, pharmaceutical companies should focus more on evidence-based solutions than just the product or brand, according to a new report from Accenture (NYSE: ACN) on product launches in the pharmaceutical industry.